Myocardial 18F-FDG-PET. Experiences with the euglycemic hyperinsulinemic clamp technique

Area of Science:

• Cardiology
• Nuclear Medicine
• Metabolic Research

Background:

• Myocardial positron emission tomography (PET) using 18F-Fluordeoxyglucose (FDG) is vital for assessing viable tissue in infarcted hearts.
• Regional FDG distribution is influenced by metabolic conditions and substrate availability, leading to uptake variations even in normal myocardium.

Purpose of the Study:

• To compare the efficacy of glucose loading versus the euglycemic hyperinsulinemic clamp (EHC) technique in stimulating myocardial FDG uptake.
• To evaluate the impact of these methods on study protocol details and result reproducibility.

Main Methods:

• Investigated two methods to stimulate myocardial FDG uptake: glucose loading and the euglycemic hyperinsulinemic clamp (EHC).
• Assessed differences in tracer dose, optimal scanning time, and reproducibility between the two techniques.
• Utilized a computer-controlled system for standardization of glucose and insulin infusions during EHC.

Main Results:

• Both glucose loading and EHC were found to be practicable methods for stimulating myocardial FDG uptake.
• The EHC technique facilitated quicker metabolic stabilization, leading to earlier and significantly increased FDG uptake compared to glucose loading.
• EHC demonstrated superior standardization and reproducibility, particularly when infusions were computer-controlled.

Conclusions:

• The euglycemic hyperinsulinemic clamp (EHC) provides a more precise framework for assessing cardiac metabolism and therapeutic intervention effects than glucose loading.
• EHC allows for rapid metabolic environment stabilization, enhancing FDG uptake and improving the accuracy of myocardial viability assessment.